Tyrosine kinase receptors as molecular targets in pheochromocytomas and paragangliomas

Clarissa A. Cassol(The Ohio State University), L. Sylvia(University Hospitals of Cleveland), Daniel A. Winer(University of Southern California), Shereen Ezzat(Princess Margaret Cancer Centre), Wei Liu(Second People’s Hospital of Yibin), Miao Guo(Ontario Institute for Cancer Research)
Modern Pathology
January 3, 2014
10.1038/modpathol.2013.233
Cited by 18

Related Papers

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma
|Nature|2019|982
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization
|Journal of Neuroinflammation|2020|609
Discovery of (10 <i>R</i> )-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- <i>2H</i> -8,4-(metheno)pyrazolo[4,3- <i>h</i> ][2,5,11]-benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
|Journal of Medicinal Chemistry|2014|587
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
|Nature Genetics|2013|374